Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
BNTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.75 - $13.29
Previous CloseN/A
Volume10.71K
Average Volume (3M)27.57K
Market Cap
$264.06M
Enterprise Value$30.13M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.79
Next Earnings
May 19, 2025EPS Estimate
-0.4Last Dividend Ex-Date
Jun 01, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-2.97
Shares Outstanding23,451,475
10 Day Avg. Volume24,124
30 Day Avg. Volume27,573
Standard Deviation0.26
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-8.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.11
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit278.98
Enterprise Value/Ebitda-1.25
Forecast
1Y Price Target
$25.33Price Target Upside118.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Benitec Biopharma News
PremiumCompany Announcements
Benitec Biopharma Strengthens Leadership with Key Appointments
PremiumCompany Announcements
Benitec Biopharma Awards Bonuses to Key Executives
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBNTC reported cash and equivalents of $78.3M to support its operations and initiatives.
Research PresentationBenitec Biopharma has been selected to present a late-breaking oral presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference, providing an excellent opportunity to highlight the potential of BB-301.
Bears Say
Market CompetitionNo treatments have been approved for OPMD, highlighting a significant unmet need and opportunity for BB-301 as the first of its kind.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNTC FAQ
What was Benitec Biopharma Ltd’s price range in the past 12 months?
Benitec Biopharma Ltd lowest stock price was $2.75 and its highest was $13.29 in the past 12 months.
What is Benitec Biopharma Ltd’s market cap?
Benitec Biopharma Ltd’s market cap is $264.06M.
When is Benitec Biopharma Ltd’s upcoming earnings report date?
Benitec Biopharma Ltd’s upcoming earnings report date is May 19, 2025 which is in 87 days.
How were Benitec Biopharma Ltd’s earnings last quarter?
Benitec Biopharma Ltd released its earnings results on Feb 14, 2025. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.776 by $0.446.
Is Benitec Biopharma Ltd overvalued?
According to Wall Street analysts Benitec Biopharma Ltd’s price is currently Undervalued.
Does Benitec Biopharma Ltd pay dividends?
Benitec Biopharma Ltd pays a Notavailable dividend of $0.51 which represents an annual dividend yield of N/A. See more information on Benitec Biopharma Ltd dividends here
What is Benitec Biopharma Ltd’s EPS estimate?
Benitec Biopharma Ltd’s EPS estimate is -0.4.
How many shares outstanding does Benitec Biopharma Ltd have?
Benitec Biopharma Ltd has 23,451,475 shares outstanding.
What happened to Benitec Biopharma Ltd’s price movement after its last earnings report?
Benitec Biopharma Ltd reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.776. Following the earnings report the stock price went up 15.979%.
Which hedge fund is a major shareholder of Benitec Biopharma Ltd?
Currently, no hedge funds are holding shares in BNTC
---
Benitec Biopharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.33 (118.93% Upside)
$25.33 (118.93% Upside)
Blogger Sentiment
Bullish
BNTC Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
275.62%
12-Months-Change
Fundamentals
Return on Equity
-46.85%
Trailing 12-Months
Asset Growth
270.29%
Trailing 12-Months
Company Description
Benitec Biopharma Ltd
Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in North Sydney, Australia.
---
BNTC Stock 12 Month Forecast
Average Price Target
$25.33
▲(118.93% Upside)
Technical Analysis
Alnylam Pharma
―
Arrowhead Pharmaceuticals
―
Bluebird Bio
―
Sorrento Therapeutics
―
Editas Medicine
―
Best Analysts Covering BNTC
1 Year
1 Year Success Rate
13/16 ratings generated profit
1 Year Average Return
+71.74%
reiterated a buy rating 3 days ago
Copying Silvan Tuerkcan's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +71.74% per trade.
---